Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story

Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story

<p>Abstract</p> <p>This review provides an update on the current state of pharmacogenetic research in the treatment of Alzheimer's disease (AD) and Lewy body disease (LBD) as it pertains to the use of cholinesterase inhibitors (ChEI). AD and LBD are first reviewed from clinica...

Full description

Bibliographic Details
Main Authors: Lam Benjamin, Hollingdrake Elizabeth, Kennedy James L, Black Sandra E, Masellis Mario
Format: Article
Language:English
Published: BMC 2009-12-01
Series:Human Genomics
Subjects:
Alzheimer's disease
cholinesterase inhibitors
endophenotype
Lewy body disease
neuroimaging
pharmacogenetics
Online Access:http://www.humgenomics.com/content/4/2/91

Internet

http://www.humgenomics.com/content/4/2/91

Similar Items